- Planting
at the Scio project in Oregon can begin in late May or early June,
extending the growing season by 45 to 60 days
- The
project has already received Oregon Department of Agriculture registration
to cultivate hemp in 2019
- Company
will cultivate three different strains of hemp, characterized by high CBD
content and a very low THC level
Marijuana Company of America Inc. (OTCQB: MCOA), an
innovative hemp and cannabis corporation, announced on January 10 that clone
production at the Scio, Oregon, high yielding CBD hemp project is underway.
MCOA and joint venture partner Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG)
(FRANKFURT: GHG) are preparing to begin planting as early as possible in 2019,
which will have a positive effect on the length of the growing season (http://ibn.fm/ilRRX).
In 2018, MCOA had a late start because of delays in
finalizing the acquisition of the Scio property – a 109-acre farm to cultivate
high yielding CBD hemp. The property is located in the fertile Willamette
Valley that has a history of hemp cultivation.
According to plans, planting can begin in late May or early
June this year. As a result, MCOA will lengthen the growing season by 45 to 60
days. The additional time will allow for the plants to grow considerably larger
and to generate a significantly larger quantity of biomass in comparison to
2018.
The company will cultivate three strains of hemp at the Scio
project this year. All three strains are characterized by high CBD content,
ultra-low levels of THC and substantial biomass yields. Additionally, the
selected strains have superior pest resistance and a shorter flowering period,
enabling earlier harvest.
The hardiest phenotypes will create the mother plants that
will be in the heart of the cloning process. MCOA started the cloning process
in November 2018, soon after the completion of the annual harvest and drying
operation. As a result of the cloning operation, MCOA expects to have
approximately 40,000 plants that will be needed for the lower 35 acres of the
farm.
MCOA is also working on expanding the scope of the cloning
operation. The Scio project team is upgrading both the light and the electrical
systems in the property greenhouses. According to preliminary estimates,
cloning operations are projected to produce a greater number of plants than
what’s required for the farm.
Getting the cloning project underway has an added benefit
for MCOA; it eliminates the need for the purchase of clones produced by
third-party growers. In 2018, the company had to adopt such an approach, which
contributed to operating expenses of more than $200,000 due to the late
acquisition of the property. There was not time to produce enough clones for
the 2018 crop.
Covered Bridge Acres (“CBA”), the project operating company,
has already received Oregon Department of Agriculture registration to cultivate
hemp in 2019. In addition, CBA has a permit to produce and handle agricultural
hemp seed, which means that a seed breeding program can be established.
MCOA specializes in the production and development of legal
hemp-derived CBD products under the hempSMART™ brand. The brand targets general
health and wellbeing.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment